VACCINE COMPOSITION CONTAINING TRANSFORMING GROWTH FACTOR ALPHA
The invention relates to a vaccine composition capable of producing a specific immune response against autologous TGF alpha, which contains TGF alpha or any derivative thereof and active ingredients and an appropriate adjuvant. The vaccine preparation can also include a combination of TGF alpha and other growth factors such as epidermic growth factor (EGF) in such a way that it inhibits the proliferation of tumors whose progression depends on said factors. The growth and proliferation of epidermoid carcinomas can be controlled with the use of said composition.